|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||70.12 - 71.12|
|52 Week Range||42.11 - 73.42|
|Beta (5Y Monthly)||0.19|
|PE Ratio (TTM)||17.42|
|Forward Dividend & Yield||0.91 (1.26%)|
|Ex-Dividend Date||Sep 28, 2020|
|1y Target Est||82.86|
Rating Action: Moody's downgrades Yestar's ratings to Caa1; outlook remains negativeGlobal Credit Research - 14 Apr 2021Hong Kong, April 14, 2021 -- Moody's Investors Service has downgraded the corporate family rating (CFR) and senior unsecured rating of Yestar Healthcare Holdings Company Limited to Caa1 from B3.The outlook on the ratings remains negative.In its 2020 results announcement dated 7 April, Yestar indicated that there are significant uncertainties as to whether the company can continue as a going concern. For provisional ratings, this announcement provides certain regulatory disclosures in relation to the provisional rating assigned, and in relation to a definitive rating that may be assigned subsequent to the final issuance of the debt, in each case where the transaction structure and terms have not changed prior to the assignment of the definitive rating in a manner that would have affected the rating.
Fujifilm Holdings Corp said on Wednesday that Shigetaka Komori, who oversaw the company's transition from film business to healthcare, would step down as chairman and chief executive in June. Komori, 81, will take a new role as chief adviser while Teiichi Goto becomes CEO and Kenji Sukeno the chairman. The transitions are subject to approval by shareholders, Fujifilm said in a release.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.